Abstract
Three mutations in the highly conserved DNA-binding region of c-MAF (R288P, K297R, and R299S) are associated with phenotypically distinct forms of autosomal dominant congenital cataract. However, the molecular mechanisms underlying this phenotypic diversity remain unclear. In this work, we have investigated the hypothesis that differential transactivation of MAF target genes could be one factor determining the phenotypic differences. Promoter constructs were generated for four human crystallin genes with conserved half-site MAF responsive elements (MARE). MAF expression constructs were constructed with the wildtype MAF sequence and with each of the three known mutations, i.e., R288P (associated with pulverulent cataract), K297R (associated with cerulean cataract), and R299S (associated with the most severe phenotype, congenital cataract, and microcornea syndrome). Transactivation was measured using luciferase reporter assays following cotransfection in HEK cells. Responsiveness to wildtype c-MAF was established for each of the four crystallin promoter constructs. The same constructs were then investigated using c-MAF mutants corresponding to each of the three mutations. A differential response was noted for each of the tested crystallin genes. The mutation R288P significantly reduced the expression of the CRYGA and CRYBA1 constructs but had no significant effect on the other two constructs. K297R did not lead to a significant reduction in expression of any of the four constructs, although there was a tendency toward reduced expression especially for the CRYGA construct. R299S, which is associated with the most severe phenotype, congenital cataract, and microcornea syndrome, was associated with the most severe overall effect on the transactivation of the four crystallin expression constructs. Our findings suggest that differential effects of mutations on the transactivation potential of c-MAF could be a molecular correlate of the striking genotype–phenotype correlations seen in cataract forms caused by mutations in the MAF gene.
Similar content being viewed by others
References
Ionides A, Francis P, Berry V, Mackay D, Bhattacharya S, Shiels A, Moore A (1999) Clinical and genetic heterogeneity in autosomal dominant cataract. Br J Ophthalmol 83:802–808
Scott MH, Hejtmancik JF, Wozencraft LA, Reuter LM, Parks MM, Kaiser-Kupfer MI (1994) Autosomal dominant congenital cataract. Interocular phenotypic variability. Ophthalmology 101:866–871
Huang B, He W (2010) Molecular characteristics of inherited congenital cataracts. Eur J Med Genet 53:347–357
Vogt A (1922) Die Spezifität angeborener und erworbener Starformen für die einzelnen Linsenzonen. Graefes Arch Clin Exp Ophthalmol 108:219–228
Armitage MM, Kivlin JD, Ferrell RE (1995) A progressive early onset cataract gene maps to human chromosome 17q24. Nat Genet 9:37–40
Litt M, Carrero-Valenzuela R, LaMorticella DM, Schultz DW, Mitchell TN, Kramer P, Maumenee IH (1997) Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2. Hum Mol Genet 6:665–668
Kramer P, Yount J, Mitchell T, LaMorticella D, Carrero-Valenzuela R, Lovrien E, Maumenee I, Litt M (1996) A second gene for cerulean cataracts maps to the beta crystallin region on chromosome 22. Genomics 35:539–542
Vanita Sarhadi V, Reis A, Jung M, Singh D, Sperling K, Singh JR, Burger J (2001) A unique form of autosomal dominant cataract explained by gene conversion between beta-crystallin B2 and its pseudogene. J Med Genet 38:392–396
Nandrot E, Slingsby C, Basak A, Cherif-Chefchaouni M, Benazzouz B, Hajaji Y, Boutayeb S, Gribouval O, Arbogast L, Berraho A, Abitbol M, Hilal L (2003) Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts. J Med Genet 40:262–267
Vanita V, Singh D, Robinson PN, Sperling K, Singh JR (2006) A novel mutation in the DNA-binding domain of MAF at 16q23.1 associated with autosomal dominant “cerulean cataract” in an Indian family. Am J Med Genet A 140:558–566
Kataoka K, Nishizawa M, Kawai S (1993) Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J Virol 67:2133–2141
Kataoka K, Noda M, Nishizawa M (1996) Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins. Oncogene 12:53–62
Ogino H, Yasuda K (1998) Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. Science 280:115–118
Blank V, Andrews NC (1997) The Maf transcription factors: regulators of differentiation. Trends Biochem Sci 22:437–441
Reza HM, Urano A, Shimada N, Yasuda K (2007) Sequential and combinatorial roles of maf family genes define proper lens development. Mol Vis 13:18–30
Reza HM, Yasuda K (2004) Roles of Maf family proteins in lens development. Dev Dyn 229:440–448
Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schrock E, Ried T, Kuehl WM (1998) Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457–4463
Berry V, Yang Z, Addison PK, Francis PJ, Ionides A, Karan G, Jiang L, Lin W, Hu J, Yang R, Moore A, Zhang K, Bhattacharya SS (2004) Recurrent 17 bp duplication in PITX3 is primarily associated with posterior polar cataract (CPP4). J Med Genet 41:e109
Semina EV, Brownell I, Mintz-Hittner HA, Murray JC, Jamrich M (2001) Mutations on the human forkhead transcription factor FOXE3 associated with anterior segment ocular dysgenesis and cataracts. Hum Mol Genet 10:231–236
Merath K, Ronchetti A (2013) Sidjanin DJ (2013) Functional analysis of HSF4 mutations found in patients with autosomal recessive congenital cataracts. Invest Ophthalmol Vis Sci 54:6646–6654
Azuma N, Hirakiyama A, Inoue T, Asaka A, Yamada M (2000) Mutations of a human homologue of the Drosophila eyes absent gene (EYA1) detected in patients with congenital cataracts and ocular anterior segment anomalies. Hum Mol Genet 9:363–366
Nischal KK (2002) Corneal abnormalities. In: Wright KW, Spiegel PH (eds) Pediatric ophthalmology and strabismus, 2nd edn. Springer, New York, pp 391–429
Jamieson RV, Perveen R, Kerr B, Carette M, Yardley J, Heon E, Wirth MG, van Heyningen V, Donnai D, Munier F, Black GC (2002) Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. Hum Mol Genet 11:33–42
Hansen L, Eiberg H, Rosenberg T (2007) Novel MAF mutation in a family with congenital cataract-microcornea syndrome. Mol Vis 13:2019–2022
Hansen L, Mikkelsen A, Nürnberg P, Nürnberg G, Anjum I, Eiberg H, Rosenberg T (2009) Comprehensive mutational screening in a cohort of Danish families with hereditary congenital cataract. Invest Ophthalmol Vis Sci 50:3291–3303
Kataoka K, Noda M, Nishizawa M (1994) Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol 14:700–712
Yamamoto T, Kyo M, Kamiya T, Tanaka T, Engel JD, Motohashi H, Yamamoto M (2006) Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements. Genes Cells 11:575–591
Yoshida T, Ohkumo T, Ishibashi S, Yasuda K (2005) The 5′-AT-rich half-site of Maf recognition element: a functional target for bZIP transcription factor Maf. Nucleic Acids Res 33:3465–3478
Xie Q, Cvekl A (2011) The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops. J Biol Chem 286:43259–43271
Wolf LV, Yang Y, Wang J, Xie Q, Braunger B, Tamm ER, Zavadil J, Cvekl A (2009) Identification of pax6-dependent gene regulatory networks in the mouse lens. PLoS ONE 4:e4159
Ring BZ, Cordes SP, Overbeek PA, Barsh GS (2000) Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development 127:307–317
Kawauchi S, Takahashi S, Nakajima O, Ogino H, Morita M, Nishizawa M, Yasuda K, Yamamoto M (1999) Regulation of lens fiber cell differentiation by transcription factor c-Maf. J Biol Chem 274:19254–19260
Kim JI, Li T, Ho IC, Grusby MJ, Glimcher LH (1999) Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc Natl Acad Sci USA 96:3781–3785
Perveen R, Favor J, Jamieson RV, Ray DW, Black GC (2007) A heterozygous c-Maf transactivation domain mutation causes congenital cataract and enhances target gene activation. Hum Mol Genet 16:1030–1038
Cvekl A, Piatigorsky J (1996) Lens development and crystallin gene expression: many roles for Pax-6. BioEssays 18:621–630
Yang Y, Cvekl A (2005) Tissue-specific regulation of the mouse alphaA-crystallin gene in lens via recruitment of Pax6 and c-Maf to its promoter. J Mol Biol 351:453–469
Yang Y, Stopka T, Golestaneh N, Wang Y, Wu K, Li A, Chauhan BK, Gao CY, Cveklová K, Duncan MK, Pestell RG, Chepelinsky AB, Skoultchi AI, Cvekl A (2006) Regulation of alphaA-crystallin via Pax6, c-Maf, CREB and a broad domain of lens-specific chromatin. EMBO J 25:2107–2118
Liu FY, Tang XC, Deng M, Chen P, Ji W, Zhang X, Gong L, Woodward Z, Liu J, Zhang L, Sun S, Liu JP, Wu K, Wu MX, Liu XL, Yu MB, Liu Y, Li DW (2012) The tumor suppressor p53 regulates c-Maf and Prox-1 to control lens differentiation. Curr Mol Med 12:917–928
Nishiguchi S, Wood H, Kondoh H, Lovell-Badge R, Episkopou V (1998) Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice. Genes Dev 12:776–781
Cvekl A, Mitton KP (2010) Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity 105:135–151
Litt M, Kramer P, LaMorticella DM, Murphey W, Lovrien EW, Weleber RG (1998) Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet 7:471–474
Graw J, Klopp N, Illig T, Preising MN, Lorenz B (2006) Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P. Graefes Arch Clin Exp Ophthalmol 244:912–919
Mackay DS, Andley UP, Shiels A (2003) Cell death triggered by a novel mutation in the alphaA-crystallin gene underlies autosomal dominant cataract linked to chromosome 21q. Eur J Hum Genet 11:784–793
Khan AO, Aldahmesh MA, Meyer B (2007) Recessive congenital total cataract with microcornea and heterozygote carrier signs caused by a novel missense CRYAA mutation (R54C). Am J Ophthalmol 144:949–952
Beby F, Commeaux C, Bozon M, Denis P, Edery P, Morle L (2007) New phenotype associated with an Arg116Cys mutation in the CRYAA gene: nuclear cataract, iris coloboma, and microphthalmia. Arch Ophthalmol 125:213–216
Santana A, Waiswol M, Arcieri ES, Cabral de Vasconcellos JP, Barbosa de Melo M (2009) Mutation analysis of CRYAA, CRYGC, and CRYGD associated with autosomal dominant congenital cataract in Brazilian families. Mol Vis 15:793–800
Bateman JB, Geyer DD, Flodman P, Johannes M, Sikela J, Walter N, Moreira AT, Clancy K, Spence MA (2000) A new betaA1-crystallin splice junction mutation in autosomal dominant cataract. Invest Ophthalmol Vis Sci 41:3278–3285
Padma T, Ayyagari R, Murty JS, Basti S, Fletcher T, Rao GN, Kaiser-Kupfer M, Hejtmancik JF (1995) Autosomal dominant zonular cataract with sutural opacities localized to chromosome 17q11-12. Am J Hum Genet 57:840–845
Qi Y, Jia H, Huang S, Lin H, Gu J, Su H, Zhang T, Gao Y, Qu L, Li D, Li Y (2004) A deletion mutation in the betaA1/A3 crystallin gene (CRYBA1/A3) is associated with autosomal dominant congenital nuclear cataract in a Chinese family. Hum Genet 114:192–197
Reddy MA, Bateman OA, Chakarova C, Ferris J, Berry V, Lomas E, Sarra R, Smith MA, Moore AT, Bhattacharya SS, Slingsby C (2004) Characterization of the G91del CRYBA1/3-crystallin protein: a cause of human inherited cataract. Hum Mol Genet 13:945–953
Klopp N, Favor J, Loster J, Lutz RB, Neuhauser-Klaus A, Prescott A, Pretsch W, Quinlan RA, Sandilands A, Vrensen GF, Graw J (1998) Three murine cataract mutants (Cat2) are defective in different gamma-crystallin genes. Genomics 52:152–158
Billingsley G, Santhiya ST, Paterson AD, Ogata K, Wodak S, Hosseini SM, Manisastry SM, Vijayalakshmi P, Gopinath PM, Graw J, Heon E (2006) CRYBA4, a novel human cataract gene, is also involved in microphthalmia. Am J Hum Genet 79:702–709
Castorino JJ, Gallagher-Colombo SM, Levin AV, Fitzgerald PG, Polishook J, Kloeckener-Gruissem B, Ostertag E, Philp NJ (2011) Juvenile cataract-associated mutation of solute carrier SLC16A12 impairs trafficking of the protein to the plasma membrane. Invest Ophthalmol Vis Sci 52:6774–6784
Hough TA, Bogani D, Cheeseman MT, Favor J, Nesbit MA, Thakker RV, Lyon MF (2004) Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. Proc Natl Acad Sci USA 101:13566–13571
Hu S, Wang B, Qi Y, Lin H (2012) The Arg233Lys AQP0 mutation disturbs aquaporino-calmodulin interaction causing polymorphic congenital cataract. PLoS ONE 7:e37637
Park JE, Son AI, Hua R, Wang L, Zhang X, Zhou R (2012) Human cataract mutations in EPHA2 SAM domain alter receptor stability and function. PLoS ONE 7:e36564
Acknowledgments
This work was supported by Grant sanctioned to VV from the Department of Biotechnology, Government of India (Grant number BT/IN/German/13/VK/2010), and the BundesministeriumfürBildung und Forschung (BMBF, project number IND 10/036) to PNR under the framework of Indo-German bilateral cooperation for research.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Vanita, V., Guo, G., Singh, D. et al. Differential effect of cataract-associated mutations in MAF on transactivation of MAF target genes. Mol Cell Biochem 396, 137–145 (2014). https://doi.org/10.1007/s11010-014-2150-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-014-2150-z